Pfizer’s mRNA injections are supplied in multiple dose vials. There are several versions available today, all extremely confusing however the first widely used version is the “purple cap” vial. This version has been supplied from the beginning of the injections roll out globally. Both, the EUA BNT162b2 product and the “fully FDA approved” (but unavailable in the US) version of COMIRNATY come in the purple cap format. The image above shows both products. Did you spot the difference?
If you are wondering whether the vials simply contain different amounts of finished drug product and different quantities of each ingredient to account for the different number of doses, I have the answer – they do not.
Review of Pfizer’s Chemistry Manufacturing and Controls module from EMA materials obtained via a data leak at the end of 2020 revealed the following information about the ingredients, dosage, and the total volume of the finished product in the vials:
Clearly, this means a 0.45 mL of drug product, when diluted with 1.8 mL of saline is supposed to deliver 5 doses of 30 mcg of mRNA each. The same dosage information, was provided in Pfizer’s briefing document for the FDA VRBPAC meeting on December 10, 2020, requesting the initial Emergency Use Authorization.
The label dosage information for Pfizer COMIRNATY currently available on the FDA website. Section 11 lists the ingredients in text form. The quantities per dose listed are the same as were provided in the FDA and EMA documents at the end of 2020. The total supplied volume of product in the vial is also the same – 0.45ml and calls for the same amount of the dilutant to arrive at the individual doses.
“COMIRNATY […] supplied as a frozen suspension in multiple dose vials with purple caps […]; each vial must be diluted with 1.8 mL of sterile 0.9% Sodium Chloride Injection, USP […]. Each 0.3 mL dose of COMIRNATY supplied in multiple dose vials with purple caps […]contains 30 mcg of a nucleoside-modified messenger RNA (mRNA) encoding the viral spike (S) glycoprotein of SARS-CoV-2. Each 0.3 mL dose of the COMIRNATY […] also includes the following ingredients: lipids (0.43 mg ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 0.05 mg 2-(polyethylene glycol 2000)-N,N-ditetradecylacetamide, 0.09 mg 1,2-distearoyl-sn-glycero-3-phosphocholine, and 0.2 mg cholesterol), 0.01 mg potassium chloride, 0.01 mg monobasic potassium phosphate, 0.36 mg sodium chloride, 0.07 mg dibasic sodium phosphate 20 dihydrate, and 6 mg sucrose. The diluent (sterile 0.9% Sodium Chloride Injection, USP) contributes an additional 2.16 mg sodium chloride per dose.”
The math clearly doesn’t add up: 225 mcg of the active mRNA substance in a vial equals to 50 mcg in a 5-dose vial and 38 mcg in a 6-dose one.
The explanation of this apparent mystery is that the mRNA injection ingredients are specified by weight while the dose administration is by liquid volume. Translation from one to the other is complicated. At the injection administration site, the untrained and unsupervised vaccinators who, no doubt, will be thrown under the proverbial bus first when this scam fully unravels, are involved in the last phase of mRNA product manufacturing – the making of the individual doses, outside of any possibility of quality control by the pharmaceutical company. If you are wondering if this violates the FD&C Act – yes, it does. This is like the illicit drug dealers cutting cocaine by hand in a basement lab, however, much less precise.
The vials, after dilution, contain 7.5 doses by liquid volume, and they always did. Pfizer relabeled vials from 5 to 6 doses without making any changes to the product but rewarding themselves with 20% more revenue while selling the same vials with the same effective number of doses. Genius. The dose therefore is sort of probabilistic. Assuming the ingredients, and especially mRNA distribute absolutely evenly in the vial after someone manually injects saline into it, turns it over 10 times, and then leaves it in the fridge for 6 hours, then each dose may be 30 mcg of mRNA. However, that’s a silly assumption. Of course, they do not. A technician draws a dose, lets the vial sit for 6 hours, draws some more doses, forgets it’s 6 hours, or forgets to put the vial into the fridge, and then decides that they too should make an extra buck by drawing the 7th dose from what is supposed to be only 5 or 6 doses – there are numerous scenarios that can be imagined (and are documented in VAERS database and other sources).
mRNA and LNPs are known to be highly unstable and to degrade rapidly. They also will not distribute evenly in a vial as this is a manually made water-fat mixture with fat tending to float to the top, especially after several hours. The doses are extremely uneven in composition of ingredients, some will contain 50%+ more mRNA and would this introduce 5-6 trillion extra mRNA molecules in the injection which will distribute all over the body in minutes, rapidly make toxic spikes, and may kill a person quickly. Pfizer’s internal pharmacovigilance report obtained by FOIA had thousands of severe adverse events and deaths documented in 2 months after roll-out with median onset below 48 hrs. Some doses will end up containing mostly water. We are all familiar with the fact that lots of people have no adverse events after the injections, while many thousands have died, got severely injured and permanently disabled by these injections. My own educated guess on this topic is that the doses from freshly opened and stirred vials would be the deadliest ones. The doses that were drawn from the vials that set on a shelf for a while, especially if the syringe is taking the liquid from the bottom of the container first will tend to be mostly harmless.
This was never tested by any regulator as no acceptance criteria for vials/doses exist.
Batches of the product are released based on self-declared testing of the bulk products by the manufacturer. Nobody can know the composition of the shots as they are administered to people with catastrophic consequences. It is NOT POSSIBLE to manufacture this product to Good Manufacturing Practice (cGMP) standards, i.e. with full assurance and verification of the ingredients and their precise quantities per dose. This was known by the manufacturers long ago when they attempted and repeatedly failed to bring any mRNA/DNA “therapy” to market in the past 20+ years.
These products are fraudulent by design.
